
Lowell, Massachusetts, United States
RevBio, Inc., is a clinical stage medical device company developing and commercializing TETRANITE®, a patented, synthetic, injectable, self-setting, and osteoconductive bone adhesive biomaterial.
- Revenue
- $10M
- Customers
- -
- Year founded
- 2014
- Funding
- -
- Team size
- 32
- Growth
- -